Evaluation of alpha-difluoromethylornithine (DFMO) as a tool to induce protective immunity against Plasmodium berghei malaria.
François
G
G
Prince Leopold Institute of Tropical Medicine, Antwerpen, Belgium.
Van Looveren
M
M
Timperman
G
G
D000818:Animals; D000518:Eflornithine / Q000627:therapeutic use*; D005260:Female; D008288:Malaria / Q000276:immunology* / Q000469:parasitology; D051379:Mice; D008807:Mice, Inbred BALB C; D018512:Parasitemia / Q000276:immunology*; D010962:Plasmodium berghei / Q000187:drug effects* / Q000276:immunology; D014344:Trypanocidal Agents / Q000627:therapeutic use*
D014344:Trypanocidal Agents; D000518:Eflornithine